{"version":"1.0","type":"link","title":"Comparative analysis of a founder BRCA2 double mutation versus single mutation carriers reveals no additional clinical risk.","author_name":"Caliendo G 외","author_url":"https://prs-insight.online/author/Caliendo%20G","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/91619","thumbnail_width":1200,"thumbnail_height":630}